87 related articles for article (PubMed ID: 21922393)
41. Biomarkers in early breast cancer and beyond: who needs all those tests?
Storz-Pfennig P; Wolf K
Lancet Oncol; 2014 Aug; 15(9):919-20. PubMed ID: 25079097
[No Abstract] [Full Text] [Related]
42. When should we give aromatase inhibitors for insomnia; early in the day or after dinner?
Ates O; Sunar V; Sever AR; Altundag K
J BUON; 2016; 21(2):521. PubMed ID: 27273969
[No Abstract] [Full Text] [Related]
43. New directions in hormone therapy for metastatic breast cancer.
Namer M
Ann Oncol; 2002; 13 Suppl 4():69-72. PubMed ID: 12401669
[No Abstract] [Full Text] [Related]
44. Re: Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer.
Milella M; Giannarelli D; Ferraresi V; Mottolese M; Botti C; Nisticò C
J Natl Cancer Inst; 2002 Nov; 94(22):1719-20; author reply 1721-2. PubMed ID: 12441328
[No Abstract] [Full Text] [Related]
45. Expensive cancer drugs with modest benefit ignite debate over solutions.
Sinha G
J Natl Cancer Inst; 2008 Oct; 100(19):1347-9. PubMed ID: 18812543
[No Abstract] [Full Text] [Related]
46. Exercise for improving bone health in women treated for stages I-III breast cancer: a systematic review and meta-analyses.
Fornusek CP; Kilbreath SL
J Cancer Surviv; 2017 Oct; 11(5):525-541. PubMed ID: 28639157
[TBL] [Abstract][Full Text] [Related]
47. Personalized medicine and cancer.
Verma M
J Pers Med; 2012 Jan; 2(1):1-14. PubMed ID: 25562699
[TBL] [Abstract][Full Text] [Related]
48. Adjuvant hormonal therapy in perimenopausal patients.
Pinto Marín A; Ballesteros García AI; Izarzugaza Perón Y; Mansó Sánchez L; López-Tarruella Cobo S; Zamora Auñón P
Adv Ther; 2011 Sep; 28 Suppl 6():39-49. PubMed ID: 21922394
[TBL] [Abstract][Full Text] [Related]
49. Update on adjuvant hormonal treatment of early breast cancer.
Lao Romera J; Puertolas Hernández TJ; Peláez Fernández I; Sampedro Gimeno T; Fernández Martínez R; Fernández Pérez I; Iranzo González Cruz V; Illarramendi Mañas JJ; Garcerá Juan S; Ciruelos Gil EM
Adv Ther; 2011 Sep; 28 Suppl 6():1-18. PubMed ID: 21922392
[TBL] [Abstract][Full Text] [Related]
50. The use of aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer.
Benson JR
J Clin Oncol; 2005 Sep; 23(27):6807-9. PubMed ID: 16170197
[No Abstract] [Full Text] [Related]
51. Do biomarker changes during neoadjuvant endocrine therapy reflect breast tumor receptor status?
Dickler M
Nat Clin Pract Oncol; 2005 Oct; 2(10):498-9. PubMed ID: 16205767
[No Abstract] [Full Text] [Related]
52. Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.
Johnston S; Pippen J; Pivot X; Lichinitser M; Sadeghi S; Dieras V; Gomez HL; Romieu G; Manikhas A; Kennedy MJ; Press MF; Maltzman J; Florance A; O'Rourke L; Oliva C; Stein S; Pegram M
J Clin Oncol; 2009 Nov; 27(33):5538-46. PubMed ID: 19786658
[TBL] [Abstract][Full Text] [Related]
53. Individualization of treatment strategies.
Fernández Ortega A; Jolis López L; Viñas Villaró G; Villanueva Vázquez R; García Arias A; González Farré X; González Jiménez S; Saura Manich C; Cortés Castán J
Adv Ther; 2011 Sep; 28 Suppl 6():19-38. PubMed ID: 21922393
[TBL] [Abstract][Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
